539 filings
Page 6 of 27
8-K
x4tr5 mviboo
21 Jul 20
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
9:25am
8-K
0lsa1o xy790
8 Jul 20
Other Events
9:31am
8-K
3bgr4za r5vr2h7c
30 Jun 20
One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board
9:31am
8-K
3rrdk fhakz1ed9o2
25 Jun 20
Other Events
10:00am
8-K
luwkw6ilvu cv4j
18 Jun 20
JanOne Launches Strategic Alternatives Process for Legacy Businesses
9:38am
8-K
7pef4 tvvbit
4 May 20
Entry into a Material Definitive Agreement
4:46pm
8-K/A
drf i1ev324
23 Apr 20
Departure of Directors or Certain Officers
6:05am
8-K
17hqpn
22 Apr 20
Departure of Directors or Certain Officers
4:30pm
NT 10-K
9sos8m9n
30 Mar 20
Notice of late annual filing
12:00am
8-K
gu76zc31u0 o2
7 Feb 20
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development
12:00am
8-K
zhg1o8oo5
10 Jan 20
Departure of Directors or Certain Officers
5:00pm
8-K
nh2njd if48e70vs
3 Dec 19
JanOne Names Tony Giordano, Ph.D., as Chief Scientific Officer
9:00am
8-K
vvbi0est
25 Nov 19
JanOne Acquires Worldwide, Exclusive License
8:00am
8-K
d8u8r7ugn7unqrr663d
15 Nov 19
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:08pm
NT 10-Q
ni2phwta
12 Nov 19
Notice of late quarterly filing
4:02pm